Ratings by RBC Capital (Daniel Busb)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/17/2025 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | Pacira Pharmaceuticals | PCRX | Downgrade | Sector Perform (Outperform) |
11.70 (22.00) |
88.03% | Details | |
| 8/1/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/13/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2021 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/10/2021 | Amneal Pharmaceuticals | AMRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/9/2021 | Endo International plc | ENDP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/29/2021 | Pfizer | PFE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/27/2021 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 7/14/2021 | Merck | MRK | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/17/2021 | Pfizer | PFE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/8/2021 | Merck | MRK | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/14/2021 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2021 | Flexion Therapeutics | FLXN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2021 | Viatris | VTRS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2021 | Eagle Pharmaceuticals | EGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2021 | Endo International plc | ENDP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/6/2021 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2021 | Pfizer | PFE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/5/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2021 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2021 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2021 | Merck | MRK | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/7/2021 | Xeris Pharmaceuticals | XERS | New Coverage | Outperform (N/A) |
4.37 (5.81) |
32.95% | Details | |
| 4/7/2021 | Teva Pharma | TEVA | New Coverage | Sector Perform (N/A) |
11.56 (31.05) |
168.6% | Details | |
| 4/7/2021 | Viatris | VTRS | New Coverage | Outperform (N/A) |
14.05 (14.16) |
0.78% | Details | |
| 4/7/2021 | Perrigo Co. | PRGO | New Coverage | Sector Perform (N/A) |
40.39 (10.72) |
-73.46% | Details | |
| 4/7/2021 | Pfizer | PFE | New Coverage | Sector Perform (N/A) |
36.28 (27.06) |
-25.41% | Details | |
| 4/7/2021 | Pacira Pharmaceuticals | PCRX | New Coverage | Outperform (N/A) |
68.89 (22.00) |
-68.07% | Details | |
| 4/7/2021 | Osmotica | OSMT | New Coverage | Outperform (N/A) |
3.45 (1.11) |
-67.83% | Details | |
| 4/7/2021 | Optinose | OPTN | New Coverage | Outperform (N/A) |
3.57 (9.60) |
168.91% | Details | |
| 4/7/2021 | Merck | MRK | New Coverage | Sector Perform (N/A) |
77.00 (123.82) |
60.81% | Details | |
| 4/7/2021 | Jazz Pharmaceuticals | JAZZ | New Coverage | Outperform (N/A) |
164.71 (182.01) |
10.5% | Details | |
| 4/7/2021 | Flexion Therapeutics | FLXN | New Coverage | Outperform (N/A) |
8.82 (25.27) |
186.51% | Details | |
| 4/7/2021 | Endo International plc | ENDP | New Coverage | Sector Perform (N/A) |
7.19 (0.29) |
-95.97% | Details | |
| 4/7/2021 | Eagle Pharmaceuticals | EGRX | New Coverage | Outperform (N/A) |
41.28 (2.14) |
-94.82% | Details | |
| 4/7/2021 | Aquestive Therapeutics | AQST | New Coverage | Outperform (N/A) |
5.21 (4.22) |
-19% | Details | |
| 4/7/2021 | Amneal Pharmaceuticals | AMRX | New Coverage | Sector Perform (N/A) |
0.08 (13.24) |
16450% | Details | |
| 4/7/2021 | Agile Therapeutics | AGRX | New Coverage | Outperform (N/A) |
2.06 (1.51) |
-26.7% | Details | |
| 4/7/2021 | Abbvie | ABBV | New Coverage | Outperform (N/A) |
106.14 (229.48) |
116.21% | Details |
